My deep and diverse experience in cancer care through radiation and chemotherapy including targeted therapy has been helping to provide patients with more accurate and most up-to-date effective treatments in oncology.
D.M. Medical Oncology from Nizam’s Institute of Medical Sciences(NIMS), Hyderabad
M.D. Radiation Oncology from MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad
M.B.B.S. from Osmania Medical College, Hyderabad
Certificate course in Essentials of Palliative Care
MRCP SCE (UK) Medical Oncology
TREATMENT AND MANAGEMENT OF HEMATOLOGICAL AND SOLID MALIGNANCIES - TARGETED THERAPY, IMMUNOTHERAPY, CHEMOTHERAPY, BONE MARROW TRANSPLANTATION, ONCOLOGICAL EMERGENCIES, SUPPORTIVE CARE, AND PALLIATIVE ONCOLOGY FOR ADVANCE CANCER PATIENTS
TREATMENT WITH IMAGE GUIDED RADIOTHERAPY (IGRT), INTENSITY MODULATED RADIOTHERAPY (IMRT), 3DCRT, BRACHYTHERAPY, CHEMOTHERAPY, PALLIATIVE RADIOTHERAPY
TREATMENT, SCREENING AND GENETIC COUNSELING FOR HEREDITARY & FAMILIAL CANCER
Senior Residency - MNJ Institute of Oncology, Hyderabad
Internship - Osmania General Hospital, Hyderabad
Winner of 42nd National Level ICON Quiz, Hyderabad
Winner of 41st National Level ICON Quiz, Ahmedabad
Winner of 40th National Level ICON Quiz, Kolkata
Winner in Poster Presentation in National Conference of ISMPOCON, Jaipur
Is exon 19 deletion different from exon 21 mutation in advanced nonsmall cell lung cancer: a single center experience – ESMO ASIA, SINGAPORE
Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: a real-world scenario – ESMO BREAST CANCER ANNUAL CONGRESS, BERLIN, GERMANY
Clinico-pathological profile, treatment and outcomes of metastatic gastric cancer: an institutional experience – 40TH ICON CONFERENCE, KOLKATA
Anaplastic lymphoma kinase positive advanced nsclc: an institutional experience - ISMPOCON JAIPUR
Comparison of weekly cisplatin with three weekly cisplatin with concurrent radiation in locally advanced head and neck cancers, ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES
Trastuzumab related cardiotoxicity in adjuvant setting: a real-world scenario, accepted for publication in SOUTH ASIAN JOURNAL OF CANCER